blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4146258

EP4146258 - CLICK OMVS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  10.02.2023
Database last updated on 16.11.2024
FormerThe international publication has been made
Status updated on  12.11.2021
Formerunknown
Status updated on  14.05.2021
Most recent event   Tooltip22.05.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Intravacc B.V.
Antonie v. Leeuwenhoeklaan 9
3721 MA Bilthoven / NL
[2023/11]
Inventor(s)01 / VAN DER LEY, Peter André
3572 DJ Utrecht / NL
02 / ZARIRI, Afshin
6882 NV Velp / NL
03 / PHIELIX, Coen Peter
3766 EW Soest / NL
04 / KRUISWIJK, Cornelia Pia
3645 EA Vinkeveen / NL
 [2023/11]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2023/11]
Application number, filing date21723743.707.05.2021
[2023/11]
WO2021EP62092
Priority number, dateEP2020017366308.05.2020         Original published format: EP 20173663
[2023/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021224439
Date:11.11.2021
Language:EN
[2021/45]
Type: A1 Application with search report 
No.:EP4146258
Date:15.03.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 11.11.2021 takes the place of the publication of the European patent application.
[2023/11]
Search report(s)International search report - published on:EP11.11.2021
ClassificationIPC:A61K39/00, A61K39/02, A61K35/74, C07K14/47
[2023/11]
CPC:
C07K14/4723 (EP); A61K39/39 (KR,US); A61K35/74 (EP);
A61K39/0011 (US); A61K39/099 (EP); A61K39/12 (EP);
A61K39/215 (US); A61K47/646 (KR); A61P31/04 (EP);
A61P31/14 (EP); A61P37/04 (US); A61K2039/55516 (EP,KR,US);
A61K2039/55555 (EP,KR); A61K2039/55594 (KR,US); C07K2319/00 (EP,KR);
C12N2770/20034 (EP); C12N2770/32334 (EP); Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/11]
TitleGerman:KLICK-OMVS[2023/11]
English:CLICK OMVS[2023/11]
French:OMV DE CHIMIE CLICK[2023/11]
Entry into regional phase22.11.2022National basic fee paid 
22.11.2022Designation fee(s) paid 
22.11.2022Examination fee paid 
Examination procedure22.11.2022Examination requested  [2023/11]
22.11.2022Date on which the examining division has become responsible
12.06.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
30.05.2023Renewal fee patent year 03
22.05.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[YA]US2010260793  (KWAK LARRY W [US], et al) [Y] 1,2,4-12,16 * abstract * [A] 13-15;
 [YA]WO2016193370  (DE STAAT DER NEDERLANDEN VERT DOOR DE MINI VAN VWS MINIIE VAN VOLKSGEZONDHEID WELZIJN EN SPORT [NL]) [Y] 1,2,4-12,16 * figure 1 * * page 31 * * example 1 * [A] 3;
 [A]WO2018167061  (DE STAAT DER NEDERLANDEN VERT DOOR DE MINI VAN VWS MINIIE VAN VOLKSGEZONDHEID WELZIJN EN SPORT [NL]) [A] 1-16 * the whole document *;
 [XY]  - AN L L ET AL, "LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR"J"6"-"1 DNA vaccine", LEUKEMIA RESEARCH, NEW YORK,NY, US, vol. 29, no. 5, ISSN 0145-2126, (20050501), pages 535 - 543, (20050501), XP027722105 [X] 13-15 * the whole document * [Y] 1,2,4-12,16
 [XY]  - DAVIDSON D J ET AL, "Letting the CAThelicidin out of the bag, as a therapeutic modulator of the adaptive immune system", LEUKEMIA RESEARCH, NEW YORK,NY, US, (20050501), vol. 29, no. 5, doi:10.1016/J.LEUKRES.2004.10.010, ISSN 0145-2126, pages 477 - 479, XP004774311 [X] 13-15 * the whole document * [Y] 1,2,4-12,16

DOI:   http://dx.doi.org/10.1016/j.leukres.2004.10.010
 [Y]  - LEO VAN DER POL ET AL, "Outer membrane vesicles as platform vaccine technology", BIOTECHNOLOGY JOURNAL, DE, (20150901), vol. 10, no. 11, doi:10.1002/biot.201400395, ISSN 1860-6768, pages 1689 - 1706, XP055465407 [Y] 1,2,4-12,16 * the whole document *

DOI:   http://dx.doi.org/10.1002/biot.201400395
 [A]  - NIGAM M. MISHRA ET AL, "Evaluation of the antibacterial and antibiofilm activities of novel CRAMP-vancomycin conjugates with diverse linkers", ORGANIC & BIOMOLECULAR CHEMISTRY, (20150101), vol. 13, no. 27, doi:10.1039/C5OB00830A, ISSN 1477-0520, pages 7477 - 7486, XP055230135 [A] 1-16 * figures 1, 2 *

DOI:   http://dx.doi.org/10.1039/C5OB00830A
by applicantWO0209746
 WO2013006055
    - SALVERDA, Vaccine, (20160000), vol. 34, pages 1025 - 1033
    - HENIKOFFHENIKOFF, PNAS, (19920000), vol. 89, pages 915 - 919
    - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 10
    - ALTSCHUL et al., Nucleic Acids Res., (19970000), vol. 25, no. 17, pages 3389 - 3402
    - KOSCIUCZUK et al., Mol Biol Rep, (20120000), vol. 39, pages 10957 - 10970
    - XHINDOLI et al., BBA, (20160000), vol. 1858, pages 546 - 566
    - Bioconjugate Chem, (20150000), vol. 26, no. 2, pages 176 - 192
    - LANG et al., Bioconjug. Chem., (20110000), vol. 22, no. 12, pages 2415 - 2422
    - CHICHILI et al., Protein Sci, (20130200), vol. 22, no. 2, pages 153 - 167
    - VITA et al., Nucleic Acids Res, (20150000), vol. 43, pages D405 - D412
    - "GenBank", Database accession no. MN908947
    - HSIEH et al., Science, (20200918), vol. 369, no. 6510, pages 1501 - 1505
    - SAUNDERS et al., Infect Immun, (19990000), vol. 67, pages 113 - 119
    - VAN DE WATERBEEMD et al., Vaccine, (20120000), vol. 30, pages 3683 - 3690
    - WATERBEEMD et al., PLoS ONE, (20130000), vol. 8, no. 1, page e54314
    - LEE et al., Proteomics, (20070000), vol. 7, pages 3143 - 3153
    - STEEGHS et al., Cell Microbiol, (20020000), vol. 4, pages 599 - 611
    - VAN DE WATERBEEMD et al., Vaccine, (20100000), vol. 28, pages 4810 - 4816
    - HARRISON et al., Emerg Infect Dis, (20130400), vol. 19, no. 4, pages 566 - 573
    - FAN GAOYI-PING WANGQUN-YING MAOXIN YAOSHUANG LIUFENG-XIANG LIFENG-CAI ZHUJING-YU YANGZHENG-LUN LIANGFENG-MIN LU, Enterovirus 71 viral capsid protein linear epitopes: Identification and characterization
    - DAMIAN GUANG WEI FOOSYLVIE ALONSOMENG CHEE PHOONN.P. RAMACHANDRANVINCENT TAK KWONG CHOWCHIT LAA POH, Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides
    - CHIA-CHYI LIUAI-HSIANG CHOUASHU-PEI LIENAHSIAO-YU LINASHIH-JEN LIUAJUI-YUAN CHANGAMENG-SHIN GUOAYEN-HUNG CHOWAWUN-SYUE YANGAKATE HSUEN-WEN CHANGA, Identification and characterization of a cross-neutralization epitope of Enterovirus 71
    - KUAN-YING ARTHUR HUANGMEI-FENG CHENYHU-CHERING HUANGSHIN-RU SHIHCHENG-HSUN CHIUJAINN-JIM LINJEN-REN WANGKUO-CHIEN TSAOTZOU-YIEN LIN, Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children
    - ZHIQIANG KUXIAOHUA YEJINPING SHIXIAOLI WANGQINGWEI LIUZHONG HUANG, Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry
    - LONGFA XUDELEI HEZHIQUN LIJUN ZHENGLISHENG YANGMIAO YUHAI YUYIXIN CHENYUQIONG QUEJAMES WAI KUO SHIH, "Protection against Lethal Enterovirus 71 Challenge in Mice by a Recombinant Vaccine Candidate Containing a Broadly Cross-Neutralizing Epitope within the VP2 EF Loop", Ningshao Xia Theranostics, (20140000), vol. 4, pages 498 - 513
    - WANG TTTAN GSHAI RPICA NNGAI LEKIERT DCWILSON IAGARCIA-SASTRE AMORAN TMPALESE P, "Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes", Proc Natl Acad Sci USA., (20101018), vol. 107, no. 44, doi:10.1073/PNAS.1013387107, pages 18979 - 84, XP002675044

DOI:   http://dx.doi.org/10.1073/PNAS.1013387107
    - VAN DE WATERBEEMD BZOMER GKAAIJK PRUITERKAMP NWIJFFELS RHVAN DEN DOBBELSTEEN GPJMLEO A.VAN DER POL, LA, "Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis", PLOS One, (20130000), vol. 8, doi:10.1371/journal.pone.0065157, page e65157, XP055522150

DOI:   http://dx.doi.org/10.1371/journal.pone.0065157
    - CHING-LIN HSIEHJORY A. GOLDSMITHJEFFREY M. SCHAUBANDREA M. DIVENEREHUNG-CHE KUOKAMYAB JAVANMARDIKEVIN C. LEDANIEL WRAPPALISON G. LEEYUTONG LIU, "Structure-based design of prefusion-stabilized SARS-CoV-2 spikes", Science, (20200900), vol. 369, doi:10.1126/science.abd0826, pages 1501 - 1505, XP055780339

DOI:   http://dx.doi.org/10.1126/science.abd0826
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.